223 related articles for article (PubMed ID: 24824922)
1. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Zhong Z; Tan W; Chen X; Wang Y
Eur J Pharmacol; 2014 Aug; 737():1-10. PubMed ID: 24824922
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.
Zhong ZF; Tan W; Tian K; Yu H; Qiang WA; Wang YT
Oncol Rep; 2017 Apr; 37(4):2016-2024. PubMed ID: 28184941
[TBL] [Abstract][Full Text] [Related]
3. Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro.
Zhong ZF; Qiang WA; Wang CM; Tan W; Wang YT
Eur J Pharmacol; 2016 Mar; 774():10-9. PubMed ID: 26607462
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
5. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
[TBL] [Abstract][Full Text] [Related]
6. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner.
Zhong ZF; Li YB; Wang SP; Tan W; Chen XP; Chen MW; Wang YT
J Cell Biochem; 2012 Aug; 113(8):2643-51. PubMed ID: 22422660
[TBL] [Abstract][Full Text] [Related]
7. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
Zhong ZF; Tan W; Qiang WW; Scofield VL; Tian K; Wang CM; Qiang WA; Wang YT
Mol Biosyst; 2016 Apr; 12(5):1626-37. PubMed ID: 26987443
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
[TBL] [Abstract][Full Text] [Related]
9. Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin.
Sun XY; Zheng YP; Lin DH; Zhang H; Zhao F; Yuan CS
Am J Chin Med; 2009; 37(3):589-96. PubMed ID: 19606517
[TBL] [Abstract][Full Text] [Related]
10. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
11. 3β-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica inhibits the proliferation and migration of MDA-MB-231 cells.
Sathya S; Sudhagar S; Vidhya Priya M; Bharathi Raja R; Muthusamy VS; Niranjali Devaraj S; Lakshmi BS
Chem Biol Interact; 2010 Dec; 188(3):412-20. PubMed ID: 20670616
[TBL] [Abstract][Full Text] [Related]
12. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
[TBL] [Abstract][Full Text] [Related]
13. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
Lee HS; Seo EY; Kang NE; Kim WK
J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
[TBL] [Abstract][Full Text] [Related]
14. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
15. VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells.
Li F; Li C; Zhang H; Lu Z; Li Z; You Q; Lu N; Guo Q
Toxicol Appl Pharmacol; 2012 Jun; 261(2):217-26. PubMed ID: 22538171
[TBL] [Abstract][Full Text] [Related]
16. Effects of furanodiene on 95-D lung cancer cells: apoptosis, autophagy and G1 phase cell cycle arrest.
Xu WS; Li T; Wu GS; Dang YY; Hao WH; Chen XP; Lu JJ; Wang YT
Am J Chin Med; 2014; 42(1):243-55. PubMed ID: 24467547
[TBL] [Abstract][Full Text] [Related]
17. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
Liu Z; Liu Z; Zhang X; Xue P; Zhang H
Biomed Pharmacother; 2014 May; 68(4):439-45. PubMed ID: 24721328
[TBL] [Abstract][Full Text] [Related]
18. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
19. Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation.
Kim WJ; Lee MY; Kim JH; Suk K; Lee WH
Cancer Lett; 2010 Oct; 296(1):35-42. PubMed ID: 20381234
[TBL] [Abstract][Full Text] [Related]
20. JNP3, a new compound, suppresses PMA-induced tumor cell invasion via NF-κB down regulation in MCF-7 breast cancer cells.
Yu HY; Kim KS; Moon HI; Kim KM; Lee YC; Lee JH
Biochem Biophys Res Commun; 2012 May; 421(2):190-6. PubMed ID: 22503685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
